Search

Your search keyword '"Shimoi T"' showing total 237 results

Search Constraints

Start Over You searched for: Author "Shimoi T" Remove constraint Author: "Shimoi T"
237 results on '"Shimoi T"'

Search Results

1. Open-label Phase II study of everolimus plus endocrine therapy in postmenopausal women with ER-positive and HER2-negative metastatic breast cancer (Chloe trial)

2. 126P Comprehensive efforts to address multifaceted issues of rare cancers and sarcomas in Japan

10. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

16. 1521O A phase II biomarker-driven study evaluating the clinical efficacy of an MDM2 inhibitor, milademetan, in patients with intimal sarcoma, an ultra-rare cancer with highly life-threatening unmet medical needs (NCCH1806/MK004)

17. 171P Combining tumor-infiltrating lymphocytes and PD-L1 expression can stratify prognosis in early-stage triple-negative breast cancer patients who did not receive adjuvant chemotherapy

19. 245P Clinicopathological features including response to platinum-based chemotherapy in endometrial carcinomas involving SWI/SNF complex inactivation

20. The survival outcomes for the subsequent therapy after treatment with trastuzumab emtansine in human epidermal growth factor receptor 2-positive metastatic breast cancer patients

21. 346P Phase I study of the liposomal formulation of eribulin (E7389-LF): Results from the HER2-negative breast cancer expansion

22. Radiation hardness of a p-channel notch CCD developed for the X-ray CCD camera onboard the XRISM satellite

23. Radiation hardness of a p-channel notch CCD developed for the X-ray CCD camera onboard the XRISM satellite

28. 64Cu-DOTA-trastuzumab PET imaging for HER2-specific primary lesions of breast cancer

33. 503O_PR CIC-rearranged sarcoma and BCOR-CCNB3 sarcoma: Clinical characteristics and treatment results of the newly-established “Ewing sarcoma-like” small round cell sarcomas

34. 118P A retrospective comparison of eribulin and capecitabine in patients with HER2-negative metastatic breast cancer

35. 511P Retrospective study of sarcoma in practical and developmental therapeutics in Japan

37. 320P Adjuvant chemotherapy comprising a paclitaxel and carboplatin regimen or paclitaxel and ifosfamide regimen for uterine carcinosarcoma, a single institutional retrospective study

38. 154P Clinical trial designs for the approval of rare cancer drugs in Japan

41. A phase 1 study of single agent veliparib in Japanese subjects with advanced solid tumors

44. Overxpression of HER2/neu in uterine carcinosarcoma

45. Single agent activity of DS-8201a, a HER2-targeting antibody-drug conjugate, in breast cancer patients previously treated with T-DM1: Phase 1 dose escalation

46. Abstract P3-14-10: Phase Ia/Ib study of taselisib (GDC-0032), a potent and selective phosphoinositide 3-kinase inhibitor, in Japanese patients with advanced solid tumors or hormone receptor-positive locally advanced or metastatic breast cancer (JO29196 study)

48. 98P BRCA1 methylation in triple-negative breast cancer

Catalog

Books, media, physical & digital resources